Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control
Clinical trial NCT07239440 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07239440
- Sponsor
- Dong-A ST Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-01
- Primary completion
- 2026-12-01
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.